Funded Tech Companies
Vernal Biosciences
Operating out of Burlington, Vernal Biosciences has funding from Charles River Laboratories, Dynamk Capital and Ampersand Capital Partners.
Company Overview
Company Name
Vernal Biosciences
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
261 Mountain View Drive
Burlington, VT 05446
USA
Burlington, VT 05446
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
We are passionate about channeling Vernal's technology and the hard work of our team to democratize mRNA R&D by making mRNA readily available to more researchers and companies. We believe that science matters more than ever and that mRNA will open many more doors for science to change the lives of humans everywhere. To help fulfill this vision, Vernal is committed to increasing access to the supply of quality mRNA.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/22/2023
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christian Cobaugh
Company Investors
- Charles River Laboratories
- Dynamk Capital (Gustavo Mahler)
- Ampersand Capital Partners (David Anderson)
- Vermont Center for Emerging Technologies
- Alloy Therapeutics (Errik Anderson)
- ATUM
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs